• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Steris wins FDA nod for new sterilization system

Steris wins FDA nod for new sterilization system

April 7, 2010 By MedCity News

By Mary Vanac

MedCity News logo

After more than a year of review, the Food & Drug Administration cleared Steris Corp.’s (NYSE:STE) System 1E next-generation liquid chemical sterilizing system.

The Mentor, Ohio-based maker of health and life sciences technologies hopes to deliver the first System 1Es by the quarter ending Sept. 30. Until then, it will continue working with the FDA to resolve the “violating device” status of its first-generation System 1, which Steris no longer makes but is supporting with supplies, parts and service during a transition period yet to be negotiated with the federal watchdog. In early February, the FDA changed its December recommendation, suggesting that hospitals and other health care facilities replace their System 1s with alternatives within 18 months.

The market approval of the new device removes at least some of the financial uncertainty posed by the nearly two-year disagreement over System 1.

“We are pleased that the agency cleared System 1E for marketing,” president and CEO Walt Rosebrough said in prepared remarks (PDF). “This is good news for our customers, and we look forward to working with them as they continue their transition to acceptable alternative technologies. We remain committed to the outstanding level of service that our customers have come to expect from Steris.”

The System 1E clearance is good news for Steris investors, too. The FDA issued a Dec. 3 safety alert warning that the company had changed System 1 so much since its 1988 launch that the regulator could no longer call it an approved device. Since then, Steris shares have lost 22 percent, bottoming at $26.08 per share Feb. 1 before rebounding to $33.96 April 6.

In early February, Steris reported higher operating profits and a modest increase in revenue for its fiscal third quarter. But the company also said future profits were unclear because it had been unable to resolve the FDA’s problems with System 1, whose supplies, parts and service typically account for 10 percent of the company’s revenues each year.

Like its predecessor, the newly approved System 1E is used by healthcare facilities to sterilize medical instruments, such as endoscopes, which cannot be sterilized with heat.

Filed Under: Business/Financial News, News Well, Sterilization / Calibration Tagged With: Gift Bans, Steris Corp.

More recent news

  • Penumbra completes enrollment in pulmonary embolism trial
  • Zoll opens new facility in Rhode Island
  • FDA expands clearance for Inquis Medical’s Aventus thrombectomy system
  • SS Innovations completes first robotic cardiac surgery in the Americas
  • GI Windows wins FDA nod for magnet tech

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy